MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Research It
- Compare Company
- International - indian pharma
- AUROBINDO PHARMA - ADCOCK INGRAM (S. Africa)
AUROBINDO PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results
AUROBINDO PHARMA Change
Aurobindo Pharma is one of India's top 5 pharma companies in terms of turnover, and has presence in the generic and Active Pharmaceutical Ingredients (API) segments. The company's robust product portfolio is spread across 6 product areas, including a... More
ADCOCK INGRAM (S. Africa)
Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More
Financials
 AUROBINDO PHARMA  ADCOCK INGRAM |
| EQUITY SHARE DATA | |||||
|---|---|---|---|---|---|
| AUROBINDO PHARMA Mar-19 |
ADCOCK INGRAM Jun-14 |
AUROBINDO PHARMA/ ADCOCK INGRAM |
5-Yr Chart Click to enlarge
|
||
| High | Rs | 830 | 383 | - | |
| Low | Rs | 527 | 276 | - | |
| Sales per share (Unadj.) | Rs | 333.9 | 113.9 | - | |
| Earnings per share (Unadj.) | Rs | 40.4 | -28.7 | - | |
| Cash flow per share (Unadj.) | Rs | 51.8 | -23.8 | - | |
| Dividends per share (Unadj.) | Rs | 2.50 | 0 | - | |
| Dividend yield (eoy) | % | 0.4 | 0 | - | |
| Book value per share (Unadj.) | Rs | 237.1 | 89.4 | - | |
| Shares outstanding (eoy) | m | 585.91 | 168.78 | - | |
| Bonus/Rights/Conversions | ESOP | - | - | ||
| Price / Sales ratio | x | 2.0 | 2.9 | 70.2% | |
| Avg P/E ratio | x | 16.8 | -11.5 | -146.4% | |
| P/CF ratio (eoy) | x | 13.1 | -13.9 | -94.6% | |
| Price / Book Value ratio | x | 2.9 | 3.7 | 77.6% | |
| Dividend payout | % | 6.2 | 0 | - | |
| Avg Mkt Cap | Rs m | 397,569 | 55,608 | 714.9% | |
| No. of employees | `000 | 17.9 | 4.3 | 415.9% | |
| Total wages/salary | Rs m | 25,849 | 3,490 | 740.6% | |
| Avg. sales/employee | Rs Th | 10,956.9 | 4,476.9 | 244.7% | |
| Avg. wages/employee | Rs Th | 1,447.7 | 813.0 | 178.1% | |
| Avg. net profit/employee | Rs Th | 1,324.3 | -1,128.1 | -117.4% | |
| INCOME DATA | |||||
|---|---|---|---|---|---|
| Net Sales | Rs m | 195,636 | 19,219 | 1,017.9% | |
| Other income | Rs m | 1,553 | 135 | 1,154.0% | |
| Total revenues | Rs m | 197,189 | 19,354 | 1,018.9% | |
| Gross profit | Rs m | 39,519 | -3,331 | -1,186.6% | |
| Depreciation | Rs m | 6,680 | 829 | 805.3% | |
| Interest | Rs m | 2,626 | 521 | 504.4% | |
| Profit before tax | Rs m | 31,767 | -4,546 | -698.8% | |
| Minority Interest | Rs m | 27 | -13 | -213.1% | |
| Prior Period Items | Rs m | 0 | 0 | - | |
| Extraordinary Inc (Exp) | Rs m | -881 | 0 | - | |
| Tax | Rs m | 7,269 | 284 | 2,558.8% | |
| Profit after tax | Rs m | 23,645 | -4,843 | -488.2% | |
| Gross profit margin | % | 20.2 | -17.3 | -116.6% | |
| Effective tax rate | % | 22.9 | -6.2 | -366.2% | |
| Net profit margin | % | 12.1 | -25.2 | -48.0% | |
| BALANCE SHEET DATA | |||||
|---|---|---|---|---|---|
| Current assets | Rs m | 153,645 | 14,076 | 1,091.5% | |
| Current liabilities | Rs m | 120,429 | 7,920 | 1,520.6% | |
| Net working cap to sales | % | 17.0 | 32.0 | 53.0% | |
| Current ratio | x | 1.3 | 1.8 | 71.8% | |
| Inventory Days | Days | 135 | 111 | 121.9% | |
| Debtors Days | Days | 64 | 124 | 51.4% | |
| Net fixed assets | Rs m | 103,909 | 8,205 | 1,266.4% | |
| Share capital | Rs m | 586 | 89 | 656.6% | |
| Net worth | Rs m | 138,908 | 15,085 | 920.8% | |
| Long term debt | Rs m | 1,800 | 5,301 | 33.9% | |
| Total assets | Rs m | 264,544 | 28,497 | 928.3% | |
| Interest coverage | x | 13.1 | -7.7 | -169.4% | |
| Debt to equity ratio | x | 0 | 0.4 | 3.7% | |
| Sales to assets ratio | x | 0.7 | 0.7 | 109.7% | |
| Return on assets | % | 9.9 | -15.2 | -65.5% | |
| Return on equity | % | 17.0 | -32.1 | -53.0% | |
| Return on capital | % | 23.8 | -19.8 | -120.3% | |
| CASH FLOW | |||||
|---|---|---|---|---|---|
| From Operations | Rs m | 16,220 | 1,640 | 988.7% | |
| From Investments | Rs m | -28,768 | -504 | 5,711.3% | |
| From Financial Activity | Rs m | 19,191 | 4,811 | 398.9% | |
| Net Cashflow | Rs m | 6,656 | 5,948 | 111.9% | |
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.28 Rs / ZAR
Compare AUROBINDO PHARMA With: ACTAVIS (US) MYLAN (US) TEVA PHARMA (Israel)
Compare AUROBINDO PHARMA With: JUBILANT PHARMOVA ELDER PHARMA ALEMBIC PHARMA GSK PHARMA NOVARTIS
Today's Market
Sensex Ends Flat; Wipro & Hindalco Industries Among Top Nifty Gainers(Closing)
Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.
Related Views On News
AUROBINDO PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 25.6% (Quarterly Result Update)
Sep 15, 2020 | Updated on Sep 15, 2020For the quarter ended June 2020, AUROBINDO PHARMA has posted a net profit of Rs 8 bn (up 25.6% YoY). Sales on the other hand came in at Rs 59 bn (up 8.8% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.
AUROBINDO PHARMA Announces Quarterly Results (4QFY20); Net Profit Up 48.2% (Quarterly Result Update)
Jun 5, 2020 | Updated on Jun 5, 2020For the quarter ended March 2020, AUROBINDO PHARMA has posted a net profit of Rs 9 bn (up 48.2% YoY). Sales on the other hand came in at Rs 62 bn (up 16.4% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.
AUROBINDO PHARMA 2018-19 Annual Report Analysis (Annual Result Update)
Nov 6, 2019 | Updated on Nov 6, 2019Here's an analysis of the annual report of AUROBINDO PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of AUROBINDO PHARMA. Also includes updates on the valuation of AUROBINDO PHARMA.
More Views on NewsMost Popular
India: Recovery Stalled by Vaccine Games? (The Honest Truth)
Apr 13, 2021Ajit Dayal on how India's vaccine strategy will impact the markets.
4 Stocks to Make Your Portfolio Immune to the Second Covid Wave (Profit Hunter)
Apr 6, 2021Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.
An India Revival Stock I'm Bullish On... (Profit Hunter)
Apr 9, 2021This could take India to the position of 3rd largest economy.
Why Did the Market Crash on Monday? (Fast Profits Daily)
Apr 13, 2021In this video, I'll you what I think is the real reason behind yesterday's market crash.
Why the Market Fell Yesterday (Fast Profits Daily)
Apr 6, 2021In this video, I'll tell you the two reasons why the market fell on Monday and how you can prepare yourself for such events in the future.
More
